Currently, the relationship between ademetionine, caplacizumab, pegaptanib sodium, lomitapide mesylate, calcitonin, urokinase, cetrorelix, iodipamide, dexrazoxane, ocriplasmin, and renal insufficiency has not been reported in the existing literature. Here, CALCA is linked to Renal insufficiency.